Landiolol, a new ultra-short-acting beta1-blocker, reduces anaesthetic requirement during sevoflurane/N(2)O/fentanyl anaesthesia in surgical patients.


BACKGROUND AND OBJECTIVE It is known that esmolol, a short-acting beta1-blocker, reduces anaesthetic requirement. In this study, we evaluated whether a low dose of landiolol, a new ultra-short-acting beta1-blocker, can reduce the sevoflurane requirement. METHODS Twenty-five patients undergoing hip surgery were randomly divided into two groups. Group A (n… (More)
DOI: 10.1097/EJA.0b013e328318c6a9